•City People Reveals Her Major Achievements
Professor Adeyeye is the hardworking Director General (DG) of Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC) where she is leading regulatory and administrative reforms through quality management approach.
She is doing so well that many people have been commending her efforts.
Let’s tell you a little about her. She is a Professor Emeritus of Pharmaceutics, Drug Product Development and Evaluation at the College of Pharmacy, Roosevelt University (RU) in Schaumburg, Illinois. She was the Founding Chair of the Department of Biopharmaceutical Sciences at Roosevelt University where she hired new faculty, built research laboratories, and procured research equipment.
Prof Adeyeye is celebrated for enhancing the scholastic capacity of the faculty members, and engaging community stakeholders (pharmaceutical and biotechnology companies) as advisory board and collaborators. Her research interest includes preformulation, pediatric and adult drug product (solids, liquids and semisolids) development and evaluation investigational new drug application-driven bench-to-bedside translational research, preclinical and clinical trials, analytical/bioanalytical assay development, bioavailability and bioequivalence quantitation, fixed-dose combination dosage forms for various drug classes including antiretrovirals, anti-malarials and anti-sickling agents. She is a Senior William J. Fulbright Scholar and Specialist, 2008 American Association of Pharmaceutical Scientists (AAPS) Fellow, 2016 Nigerian National Academy of Science Fellow and 2017 Nigeria Academy of Pharmacy Fellow.
She earned her B.S., and M.S./PhD from the University of Nigeria, Nsukka, Nigeria, and University of Georgia, Athens, GA, respectively. She has 5 patents, 62 peer-reviewed manuscripts, book chapters and books, more than 150 scientific presentations and successfully mentored many MS and PhD candidates. She founded Elim Pediatric Pharmaceuticals Inc. (EPPI), a socially conscious company, in order to develop drugs for HIV/AIDS children. She was the President/CEO of EPPI until she was appointed as DG of NAFDAC.
HER Major achievements
The following achievements has been recorded thus far:
·Inherited debt of 3.01 billion naira paid
·6000 backlog of applications cleared in 2 months and s new Ease of doing Business approach adopted using quality management system approach
·De-centralization of food registration to the Zones for efficiency and faster time for product approval
·Food registration for MSMEs is now a maximum of 90 working days. Drug product application time for approval is 120 working days
·QMS certification ISO 1900/2015 Certification
·Change in governance to a transparent, more accountable and efficient system, and the resultant development of a more disciplined and motivating workforce
·Creation of six more Directorates and six Director positions for the six Zonal Offices
·Global benchmarking tooling (GBT) of all regulatory activities leading to use of international standards and best practices
·GMP roadmap for local Pharmaceuticals (165 companies) to emphasize compliance with GMP and to ensure the quality of locally manufactured medicines
·Overhauling of Pre-shipment inspection and testing criteria for regulated products coming from India and China to ensure the quality of medicines and other products being imported into Nigeria
·Lab ISO 17025 Certification for the Vaccines and Biologics Lab and yearly re-accreditation for the other four previously accredited labs
·Digitalization of regulatory activities through use of various ICT tools, video-conferencing and resultant increased efficiency and reduction in unnecessary travels
·Increased internally generated revenues for the last two years
·Restoration of NAFDAC’s mandate to control of importation by returning the Agency back to the Ports after seven-year absence Clean Report of Inspection and Analysis (CRIAs) consultants in India, China
·Clean Report of Inspection and Analysis (CRIAs) consultants in India, China & Egypt for Quality assurance and control of products imports from these countries.
·More engaging public awareness, the enlightenment of NAFDAC’s activities through weekly TV (NAFDAC & Your Health) and radio (FRCN)
·Internationally recognized leadership role of NAFDAC among African regulatory agencies
·More collaborations with sister agencies such as PCN, SON, NCDC, NEPC, Customs, Shippers Council, etc. and government units such as NHREC.
